Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease

Journal of Neuroscience

Volumn 33, Issue 5, 2013, Pages 2147-2155

  Douaud, Gwenaëlle ^a   Menke, Ricarda A L ^a,g   Gass, Achim ^b   Monsch, Andreas U ^b   Rao, Anil ^c   Whitcher, Brandon ^c,d   Zamboni, Giovanna ^a,e   Matthews, Paul M ^c,f   Sollberger, Marc ^b   Smith, Stephen ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Mango Solutions   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN [1-42]; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN; BRAIN DISEASE; BRAIN STRUCTURE; COGNITION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; EARLY DIAGNOSIS; EPISODIC MEMORY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; ALZHEIMER DISEASE; AMNESIA; AMYLOID BETA-PEPTIDES; ATROPHY; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 84873031441     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4437-12.2013     Document Type: Article

References (63)

1. Agosta F, Pievani M, Sala S, Geroldi C, Galluzzi S, Frisoni GB, Filippi M (2011) White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 258:853-863. CrossRef Medline
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association.
3. Amunts K, Kedo O, Kindler M, Pieperhoff P, Mohlberg H, Shah NJ, Habel U, Schneider F, Zilles K (2005) Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol (Berl) 210:343-352. CrossRef Medline
4. Buckner RL, Snyder AZ, Shannon BJ, La Rossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25:7709-7717. CrossRef Medline
5. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA (2009) Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 29:1860-1873. CrossRef Medline
6. Cairns NJ, Chadwick A, Luthert PJ, Lantos PL (1992) Astrocytosis, beta A4-protein deposition and paired helical filament formation in Alzheimer's disease. J Neurol Sci 112:68-75. CrossRef Medline
7. Copenhaver BR, Rabin LA, Saykin AJ, Roth RM, Wishart HA, Flashman LA, Santulli RB, McHugh TL, Mamourian AC (2006) The fornix and mam-millary bodies in older adults with Alzheimer's disease, mild cognitive impairment, and cognitive complaints: a volumetric MRI study. Psychiatry Res 147:93-103. CrossRef Medline
8. Costafreda SG, Dinov ID, Tu Z, Shi Y, Liu CY, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Wahlund LO, Spenger C, Toga AW, Lovestone S, Simmons A (2011) Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuro-image 56:212-219. CrossRef Medline
9. Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ (2011) Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 32:2322.e19-2322.e27. CrossRef Medline
10. Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Greve DN, Salat DH, Buckner RL, Alzheimer's Disease Neuroimaging Initiative (2009) Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain 132:2048-2057. CrossRef Medline
11. Douaud G, Smith S, Jenkinson M, Behrens T, Johansen-Berg H, Vickers J, James S, Voets N, Watkins K, Matthews PM, James A (2007) Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 130:2375-2386. CrossRef Medline
12. Douaud G, Jbabdi S, Behrens TE, Menke RA, Gass A, Monsch AU, Rao A, Whitcher B, Kindlmann G, Matthews PM, Smith S (2011) DTI measures in crossing fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroim-age 55:880-890. CrossRef Medline
13. Duchesnay E, Roche A, Riviere D, Papadopoulos D, Cointepas Y, Mangin JE (2004) Population classification based on structural morphometry of cortical sulci. In: Second IEEE international symposium on biomedical imaging: macro to nano, Vol 2, pp 1267-1270. Piscataway Township, NJ: Institute of Electrical and Electronics Engineers. 10.1109/ISBI.2004.1398776>
14. Ennis DB, Kindlmann G(2006)Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images. Magn Reson Med 55:136-146. CrossRef Medline
15. Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR Jr, Feldman HH, Bokde AL, Alexander GE, Scheltens P, Vellas B, Dubois B, Weiner M, Hampel H (2012) Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging 33:1203-1214. CrossRef Medline
16. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349-1356. CrossRef Medline
17. Fellgiebel A, Dellani PR, Greverus D, Scheurich A, Stoeter P, Müller MJ (2006) Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus. Psychiatry Res 146:283-287. CrossRef Medline
18. Fennema-Notestine C, Hagler DJ Jr, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM (2009) Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Alzheimer's Disease Neuroimaging Initiative. Hum Brain Mapp 30:3238-3253. CrossRef Medline
19. Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV (2011) Neu-rostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiol Aging 32:1733-1741. CrossRef Medline
20. Friston K (2012) Ten ironic rules for non-statistical reviewers. Neuroimage 61:1300-1310. CrossRef Medline
21. Ganguli M (2006) Mild cognitive impairment and the 7 uses of epidemiology. Alzheimer Dis Assoc Disord 20:S52-S57. CrossRef Medline
22. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B (2006) Mild cognitive impairment. International Psychoge-riatric Association Expert Conference. Lancet 367:1262-1270. CrossRef Medline
23. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21-36. CrossRef Medline
24. Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 101:4637-4642. CrossRef Medline
25. Haller S, Nguyen D, Rodriguez C, Emch J, Gold G, Bartsch A, Lovblad KO, Giannakopoulos P (2010) Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data. J Alzheimers Dis 22:315-327. CrossRef Medline
26. Hoeft F, Barnea-Goraly N, Haas BW, Golarai G, Ng D, Mills D, Korenberg J, Bellugi U, Galaburda A, Reiss AL (2007) More is not always better: increased fractional anisotropy of superior longitudinal fasciculus associated with poor visuospatial abilities in Williams syndrome. J Neurosci 27:11960-11965. CrossRef Medline
27. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128. CrossRef Medline
28. Jeurissen B, Leemans A, Tournier JD, Jones DK, Sijbers J (2012) Investigating the prevalence of complex fiber configurations in white matter tissue with diffusion magnetic resonance imaging. Hum Brain Mapp Advance online publication. Retrieved May 19, 2012. doi:10.1002/hbm.22099. CrossRef Medline
29. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, Shiung MM, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr (2005) DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64:902-904. CrossRef Medline
30. Lustig C, Snyder AZ, Bhakta M, O'Brien KC, McAvoy M, Raichle ME, Morris JC, Buckner RL (2003) Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A 100:14504-14509. CrossRef Medline
31. Maioli F, Coveri M, Pagni P, Chiandetti C, Marchetti C, Ciarrocchi R, Rug-gero C, Nativio V, Onesti A, D'Anastasio C, Pedone V (2007) Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Arch Geron-tol Geriatr 44 [Suppl 1]:233-241. CrossRef Medline
32. Makris N, Kennedy DN, McInerney S, Sorensen AG, Wang R, Caviness VS Jr, Pandya DN (2005) Segmentation of subcomponents within the superior longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study. Cereb Cortex 15:854-869. CrossRef Medline
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944. CrossRef Medline
34. Mesulam MM (1998) From sensation to cognition. Brain 121:1013-1052. CrossRef Medline
35. Mielke MM, Kozauer NA, Chan KC, George M, Toroney J, Zerrate M, Bandeen-Roche K, Wang MC, Vanzijl P, Pekar JJ, Mori S, Lyketsos CG, Albert M (2009) Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 46:47-55. CrossRef Medline
36. Miller G (2012) Alzheimer's research: stopping Alzheimer's before it starts. Science 337:790-792. CrossRef Medline
37. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42:85-94. CrossRef Medline
38. Misra C, Fan Y, Davatzikos C (2009) Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 44:1415-1422. CrossRef Medline
39. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Tro-janowski JQ, Toga AW, Beckett L (2005) Ways toward anearly diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 1:55-66. CrossRef Medline
40. Nichols TE, Holmes AP (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15:1-25. CrossRef Medline
41. O'Dwyer L, Lamberton F, Bokde AL, Ewers M, Faluyi YO, Tanner C, Mazoyer B, O'Neill D, Bartley M, Collins DR, Coughlan T, Prvulovic D, Hampel H (2011) Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease. PLoS One 6:e21745. CrossRef Medline
42. Oishi K, Akhter K, Mielke M, Ceritoglu C, Zhang J, Jiang H, Li X, Younes L, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Mori S (2011) Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front Neurol 2:54. CrossRef Medline
43. Petersen RC (2009) Early diagnosis of Alzheimer's disease: is MCI too late? Curr Alzheimer Res 6:324-330. CrossRef Medline
44. Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR Jr, Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW (2010) Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74:201-209. CrossRef Medline
45. Pike CJ, Cummings BJ, Monzavi R, Cotman CW (1994) Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63:517-531. CrossRef Medline
46. Salat DH, Tuch DS, van der Kouwe AJ, Greve DN, Pappu V, Lee SY, Hevelone ND, Zaleta AK, Growdon JH, Corkin S, Fischl B, Rosas HD (2010) White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging 31:244-256. CrossRef Medline
47. Santillo AF, Gambini JP, Lannfelt L, Långström B, Ulla-Marja L, Kilander L, Engler H (2011) In vivo imaging of astrocytosis in Alzheimer's disease: an (1)(1)C-L-deuteriodeprenyl and PIB PET study. Eur J Nucl Med Mol Imaging 38:2202-2208. CrossRef Medline
48. Schroeter ML, Stein T, Maslowski N, Neumann J (2009) Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 47: 1196-1206. CrossRef Medline
49. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6:487-498. CrossRef Medline
50. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Mat-thewsPM (2004) Advancesin functional and structural MR image analysis and implementation as FSL. Neuroimage [23 Suppl] 1:S208-S219. CrossRef Medline
51. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: voxelwise analysis of multisubject diffusion data. Neuroimage 31:1487-1505. CrossRef Medline
52. Steele ML, Robinson SR (2010) Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol Aging 33: 423.e1-423.e13. CrossRef Medline
53. Teipel SJ, Born C, Ewers M, Bokde AL, Reiser MF, Möller HJ, Hampel H (2007) Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage 38: 13-24. CrossRef Medline
54. Thomas AG, Koumellis P, Dineen RA (2011) The fornix in health and disease: an imaging review. Radiographics 31:1107-1121. CrossRef Medline
55. Tondelli M, Wilcock GK, Nichelli P, De Jager CA, Jenkinson M, Zamboni G (2012) Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging 33:825.e25-825.e36. CrossRef Medline
56. Trachtenberg AJ, Filippini N, Mackay CE (2012) The effects of APOE-epsilon4 on the BOLD response. Neurobiol Aging 33:323-334. CrossRef Medline
57. Van Camp N, Blockx I, Camón L, de Vera N, Verhoye M, Veraart J, Van Hecke W, Martínez E, Soria G, Sijbers J, Planas AM, Van der Linden A (2012) A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease. Neurobiol Aging 33:945-959. CrossRef Medline
58. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr (2009) MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Alzheimer's Disease Neuroimaging Initiative. Neurology 73:294-301. CrossRef Medline
59. Villain N, Desgranges B, Viader F, de la Sayette V, Mézenge F, Landeau B, Baron JC, Eustache F, Chételat G (2008) Relationships between hip-pocampal atrophy, white matter disruption, and gray matter hypometab-olisminAlzheimer's disease. JNeurosci 28:6174-6181. CrossRef Medline
60. Wheeler-Kingshott CA, Cercignani M (2009) About "axial" and "radial" diffusivities. Magn Reson Med 61:1255-1260. CrossRef Medline
61. Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr (2008) MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 70:512-520. CrossRef Medline
62. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nor-dberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, et al. (2004) Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256:240-246. CrossRef Medline
63. Zhuang L, Wen W, Zhu W, Trollor J, Kochan N, Crawford J, Reppermund S, Brodaty H, Sachdev P (2010) White matter integrity in mild cognitive impairment: a tract-based spatial statistics study. Neuroimage 53:16-25. CrossRef Medline